Searched over 200M research papers
5 papers analyzed
These studies suggest that monocyte activation after influenza vaccination can predict vaccine response, enhance protection against secondary challenges, and rapidly activate immune cells, with specific implications for HIV-infected individuals and vaccine design.
20 papers analyzed
Monocyte activation plays a crucial role in the immune response to influenza vaccination. Understanding how monocytes and their derived cells respond to the vaccine can provide insights into vaccine efficacy and potential improvements, especially in different populations such as older adults and individuals with compromised immune systems.
Age-Related Differences in Monocyte Activation:
Monocyte-Derived Dendritic Cells (moDCs) and T-Cell Activation:
Immune Activation in HIV-Infected Individuals:
Mechanisms of Immune Activation by Split Virus Influenza Vaccine:
Monocyte activation after influenza vaccination varies significantly with age, with older adults showing reduced activation and vaccine response. Monocyte-derived dendritic cells play a vital role in enhancing T-cell responses and protection against secondary influenza challenges. In HIV-infected individuals, influenza vaccination can increase HIV-1 replication but does not significantly alter CD4 counts or apoptosis. The split virus influenza vaccine activates immune cells through Fcγ receptors, relying on pre-existing antibodies to form immune complexes. These insights highlight the importance of monocyte activation in vaccine efficacy and the need for tailored vaccination strategies for different populations.
Most relevant research papers on this topic